A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
Clinical trial NCT03498716 · TERMINATED
Trial details
- NCT number
- NCT03498716
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-02
- Primary completion
- 2023-08-14
- Enrollment
- 2199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.